- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07306429
Evaluation of the Efficiency of Bone Born Intra Oral Distractor for Closure of Wide Alveolar Cleft (BBID-WAC)
January 4, 2026 updated by: Hanaa Elmorsy, Faculty of Dental Medicine for Girls
The study aimed to determine efficiency of Bone-Born Intraoral Distractor on wide Alveolar cleft patients
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Stereographic models were used for construction of bone-born custom-made intraoral distractor according to the inclusion and exclusion criteria, followed up to measure and determine the efficiency of the distractor
Study Type
Interventional
Enrollment (Actual)
8
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Cairo Governorate
-
Cairo, Cairo Governorate, Egypt, 12345
- Faculty of oral and dental medicine for Girls AlAzhar University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Patients with wide alveolar clefts more than 8ml either unilateral or bilateral or median facial cleft.
- Patients who had previous failed grafting also may be included.
- Age range of patients 7-20 years old, with no gender prediction, able to read and sign the informed consent (parents)
- Patients with median facial clefts.
Exclusion Criteria:
- Narrow alveolar cleft
- Syndromic patients.
- Oral soft tissues defects, inflammation, infections and bone metabolism disturbance.
- Allergy to titanium implant.
- Patient with systemic disease and immunocompromised patient.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Bone-Borne Intra-oral distractor
Surgeries to fix the device were conducted under GA.
Then latency period of seven days was applied.
Activation was 0.5 mm twice a day.
The transport segment touched the docking site then the Consolidation period is achieved.
Follow up for 6 months.
|
Evaluation of the efficiency of the Bone-Borne Intraoral distractors on wide Alveolar cleft
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in alveolar cleft defect area measured by cone-beam computed tomography (CBCT) (minimum value: 0 mm²; no predefined maximum value; lower values indicate better outcome)
Time Frame: 6 months postoperative follow up
|
The alveolar cleft defect area will be quantitatively measured using cone-beam computed tomography (CBCT).
Preoperative and postoperative CBCT scans will be superimposed to calculate the change in defect area following distraction osteogenesis.
|
6 months postoperative follow up
|
|
Change in tooth mobility assessed using Miller's Tooth Mobility Index (minimum score: 0; maximum score: 3; higher scores indicate worse mobility)
Time Frame: 6 months postoperative follow up
|
Tooth mobility will be clinically evaluated using Miller's Tooth Mobility Index to detect and grade the degree of mobility before and after treatment.
|
6 months postoperative follow up
|
|
Vitality of the transported bone segment assessed by clinical vitality indicators after transport distraction osteogenesis (binary outcome: viable / non-viable; viable outcome indicates better result)
Time Frame: 6 months follow up
|
Vitality of the transported disk after transport distraction osteogenesis is measured through clinical indicators as No infection, No pain or inflammation, Stable transported segment, Successful consolidation phase.
|
6 months follow up
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Study Chair: Hanaa Elmorsy, Assis.Lec, Assistant lecturer of OMFs department Azhar University
- Study Director: Susan H Abdel Hakim, professor, Professor of OMFs department azhar university
- Study Director: Wael Shawkat, Consultant, Head of the department at the Health Insurance Hospital
- Study Director: Fatema khalifa, Assist.Prof, Assistant Professor of OMFs Azhar university
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
March 14, 2023
Primary Completion (Actual)
June 29, 2025
Study Completion (Actual)
December 1, 2025
Study Registration Dates
First Submitted
November 30, 2025
First Submitted That Met QC Criteria
December 13, 2025
First Posted (Estimated)
December 29, 2025
Study Record Updates
Last Update Posted (Actual)
January 7, 2026
Last Update Submitted That Met QC Criteria
January 4, 2026
Last Verified
November 1, 2025
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- ORSUR-10
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
IPD Plan Description
Detailed Protocol
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Alveolar Cleft
-
October 6 UniversityMinistry of Health, KuwaitCompletedAlveolar Cleft | Alveolar Ridge CleftKuwait
-
Tanta UniversityCompleted
-
Assiut UniversityNot yet recruiting
-
Malmö UniversityRegion SkaneCompleted
-
Tanta UniversityCompleted
-
Assiut UniversityUnknown
-
Cairo UniversityNot yet recruiting
-
Cairo UniversityRecruiting
Clinical Trials on Bone-borne Intra oral distractor
-
Aalborg University HospitalRecruiting
-
Ain Shams UniversityCompletedDistraction of Bone | Cleft Lip and/or PalateEgypt
-
Oasi Research Institute-IRCCSNot yet recruiting
-
University of Roma La SapienzaCompletedOrthodontic Relapse | Orthodontic Appliances | Orthodontic ApplianceItaly
-
Sarah Ahmed SamehCairo UniversityUnknown
-
Alexandria UniversityCompleted
-
TC Erciyes UniversityCompletedTransverse Maxillary DeficiencyTurkey
-
Central Hospital, Nancy, FranceRecruitingPeriodontitis | Gingivitis | Dental Plaque | Missing Teeth | Dental Decay | Calculus, Dental | Periodontal AbscessFrance
-
Paolone GaetanoCompletedColor Detection of Upper Central IncisorsItaly
-
Mohamed Mahmoud DohiemRecruiting